Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit Pharmaceutical Investing
NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss Psychedelics Investing
Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting Pharmaceutical Investing
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries Life Science Investing
Systematic Review and Meta-Analysis of Real-World Observational Studies Provide Additional Evidence of Effectiveness of PREVYMIS in Preventing Cytomegalovirus Infection and Disease in Adults Undergoing Allogeneic HCT Life Science Investing
FDA Approves Merck's KEYTRUDA® for Patients With MSI?H/dMMR Advanced Endometrial Carcinoma, Who Have Disease Progression Following Prior Systemic Therapy in Any Setting and Are Not Candidates for Curative Surgery or Radiation Life Science Investing
Nirvana Reports Progress with Health Canada Dealer's License Application and Facility Development Psychedelics Investing
AUPH INVESTOR NOTICE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program Medical Device Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
